NFE2 and heart failure: Furthermore, NFE2 is increased in myocardium of anti-miR-132-treated porcine hearts with percutaneous transverse aortic constriction compared with the control group at the 8-week time point, indicating that this could be an effective therapeutic strategy for patients with heart failure (104).